Reliability of serum metabolite concentrations over a 4-month period using a targeted metabolomic approach

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Floegel, Anna ^a   Drogan, Dagmar ^a   Wang Sattler, Rui ^b   Prehn, Cornelia ^b   Illig, Thomas ^b   Adamski, Jerzy ^b   Joost, Hans Georg ^a   Boeing, Heiner ^a   Pischon, Tobias ^a,c  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLCARNITINE; AMINO ACID; GLYCEROPHOSPHOLIPID; HEXOSE; MONOUNSATURATED FATTY ACID; SPHINGOLIPID; SPHINGOMYELIN;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION COEFFICIENT; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; LIMIT OF DETECTION; MALE; METABOLITE; METABOLOMICS; NORMAL HUMAN; PHOSPHOLIPID BLOOD LEVEL; RELIABILITY; RISK ASSESSMENT; MIDDLE AGED; REPRODUCIBILITY; SERUM;

FEMALE; HUMANS; MALE; METABOLOMICS; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SERUM;

EID: 79958794156     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021103     Document Type: Article

References (33)

1. Weinberger KM, (2008) [Metabolomics in diagnosing metabolic diseases]. Ther Umsch 65: 487-491.
2. Vinayavekhin N, Homan EA, Saghatelian A, (2010) Exploring disease through metabolomics. ACS Chem Biol 5: 91-103.
3. Gowda GA, Zhang S, Gu H, Asiago V, Shanaiah N, et al. (2008) Metabolomics-based methods for early disease diagnostics. Expert Rev Mol Diagn 8: 617-633.
4. Lin D, Hollander Z, Meredith A, McManus BM, (2009) Searching for 'omic' biomarkers. Can J Cardiol 25 (Suppl A): 9A-14A.
5. Fleiss J, (1986) Reliability of measurement. In: Fleiss JL, editors. The design and analysis of clinical experiments Wiley and Sons New York pp. p.1-32.
6. Lewis GD, Asnani A, Gerszten RE, (2008) Application of metabolomics to cardiovascular biomarker and pathway discovery. J Am Coll Cardiol 52: 117-123.
7. Illig T, Gieger C, Zhai G, Romisch-Margl W, Wang-Sattler R, et al. (2010) A genome-wide perspective of genetic variation in human metabolism. Nat Genet 42: 137-141.
8. Wang-Sattler R, Yu Y, Mittelstrass K, Lattka E, Altmaier E, et al. (2008) Metabolic profiling reveals distinct variations linked to nicotine consumption in humans--first results from the KORA study. PLoS One 3: e3863.
9. Weikert C, Westphal S, Luley C, Willich SN, Boeing H, et al. (2007) Within-subject variation of plasma resistin levels over a 1-year period. Clin Chem Lab Med 45: 899-902.
10. Strnadova KA, Holub M, Muhl A, Heinze G, Ratschmann R, et al. (2007) Long-term stability of amino acids and acylcarnitines in dried blood spots. Clin Chem 53: 717-722.
11. Zivkovic AM, Wiest MM, Nguyen UT, Davis R, Watkins SM, et al. (2009) Effects of sample handling and storage on quantitative lipid analysis in human serum. Metabolomics 5: 507-516.
12. Zelena E, Dunn WB, Broadhurst D, Francis-McIntyre S, Carroll KM, et al. (2009) Development of a robust and repeatable UPLC-MS method for the long-term metabolomic study of human serum. Anal Chem 81: 1357-1364.
13. Pischon T, Hotamisligil GS, Rimm EB, (2003) Adiponectin: stability in plasma over 36 hours and within-person variation over 1 year. Clin Chem 49: 650-652.
14. Kaplan RC, Ho GY, Xue X, Rajpathak S, Cushman M, et al. (2007) Within-individual stability of obesity-related biomarkers among women. Cancer Epidemiol Biomarkers Prev 16: 1291-1293.
15. Kotsopoulos J, Tworoger SS, Campos H, Chung FL, Clevenger CV, et al. (2010) Reproducibility of plasma and urine biomarkers among premenopausal and postmenopausal women from the Nurses' Health Studies. Cancer Epidemiol Biomarkers Prev 19: 938-946.
16. Crews B, Wikoff WR, Patti GJ, Woo HK, Kalisiak E, et al. (2009) Variability analysis of human plasma and cerebral spinal fluid reveals statistical significance of changes in mass spectrometry-based metabolomics data. Anal Chem 81: 8538-8544.
17. McBride KL, Belmont JW, O'Brien WE, Amin TJ, Carter S, et al. (2007) Heritability of plasma amino acid levels in different nutritional states. Mol Genet Metab 90: 217-220.
18. Adams SH, Hoppel CL, Lok KH, Zhao L, Wong SW, et al. (2009) Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women. J Nutr 139: 1073-1081.
19. Mihalik SJ, Goodpaster BH, Kelley DE, Chace DH, Vockley J, et al. (2010) Increased Levels of Plasma Acylcarnitines in Obesity and Type 2 Diabetes and Identification of a Marker of Glucolipotoxicity. Obesity (Silver Spring).
20. Zhao X, Peter A, Fritsche J, Elcnerova M, Fritsche A, et al. (2009) Changes of the plasma metabolome during an oral glucose tolerance test: is there more than glucose to look at? Am J Physiol Endocrinol Metab 296: E384-393.
21. Pavoine C, Pecker F, (2009) Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology. Cardiovasc Res 82: 175-183.
22. Zhang P, Liu B, Jenkins GM, Hannun YA, Obeid LM, (1997) Expression of neutral sphingomyelinase identifies a distinct pool of sphingomyelin involved in apoptosis. J Biol Chem 272: 9609-9612.
23. Soares JC, Dippold CS, Wells KF, Houck P, Mallinger AG, (1999) Reproducibility of in vivo measures of platelet membrane phospholipids in human subjects. Psychiatry Res 86: 107-112.
24. Boeing H, Wahrendorf J, Becker N, (1999) EPIC-Germany--A source for studies into diet and risk of chronic diseases. European Investigation into Cancer and Nutrition. Ann Nutr Metab 43: 195-204.
25. Bergmann MM, Bussas U, Boeing H, (1999) Follow-up procedures in EPIC-Germany--data quality aspects. European Prospective Investigation into Cancer and Nutrition. Ann Nutr Metab 43: 225-234.
26. Boeing H, Korfmann A, Bergmann MM, (1999) Recruitment procedures of EPIC-Germany. European Investigation into Cancer and Nutrition. Ann Nutr Metab 43: 205-215.
27. Römisch-Margl W, Prehn C, Bogumil R, Röhring C, Suhre K, et al. (2011) Procedure for tissue sample preparation and metabolite extraction for high throughput targeted metabolomics. Metabolomics Epub: 03/11/2011.
28. Boulat O, Janin B, Francioli P, Bachmann C, (1993) Plasma carnitines: reference values in an ambulatory population. Eur J Clin Chem Clin Biochem 31: 585-589.
29. Koeberl DD, Young SP, Gregersen NS, Vockley J, Smith WE, et al. (2003) Rare disorders of metabolism with elevated butyryl- and isobutyryl-carnitine detected by tandem mass spectrometry newborn screening. Pediatr Res 54: 219-223.
30. Oresic M, (2009) Metabolomics, a novel tool for studies of nutrition, metabolism and lipid dysfunction. Nutr Metab Cardiovasc Dis 19: 816-824.
31. Rosner B, (2006) One-way ANOVA- the random-effects model. In: Rosner B, editors. Fundamentals of biostatistics Belmont, CA Duxbury pp. 606-613.
32. Rosner B, (2006) The intraclass correlation coefficient. In: Rosner B, editors. Fundamentals of biostatistics Belmont, CA Duxbury pp. 613-618.
33. Hartung J, (1981) Nonnegative minimum biased invariant estimation in variance component models. The Annals of Statistics 9: 278-292.